Default company panoramic image
71755ca1 1719 4f23 bc7c 2bb29c918c74

[email protected]

Acceleration BioPharmaceuticals, Inc. develops a broad-spectrum antiviral to treat HIV, HCV, HSV and Influenza Virus infections.

  • Stage Not Set
  • Industry Biotechnology
  • Location Bow, NH, USA
  • Currency USD

Company Summary

Acceleration BioPharmaceuticals develops anti-virasl using a novel concept where an interacellar antiviral activity of infected cells is activated. This prevents the advent of drug-resistant viruses and toxicity a current product with traditional drug design.


  • Default avatar
    Ralf Geiben-Lynn
    CEO and CSO

    Ralf Geiben-Lynn, Ph.D., MBA is the Chief Executive Officer and the Chief Scientific Officer of Acceleration BioPharmaceuticals, Inc. He received his Ph.D. in biology at the Justus-Liebig University/Germany. He did his post-doctoral research training in Dr. Bruce Walker’s laboratory at the Massachusetts General Hospital and Harvard Medical School, and was Group Leader at the Dr. Norman Letvin's laboratory at the Beth Israel Deaconess Medical Cent

  • Default avatar
    Nancy Levy

    Entrepreneurial biopharmaceutical executive with broad expertise focused on strategy, development and launch of innovative products and services. A hands-on, action oriented professional who is skilled in creating and executing strategic business plans. Her experience ranges from planning and execution of key business initiatives to business development, and market driven sales. Nancy has a strong business-building track record and a demonstrated